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Consumer productsChemicals such as phthalates, parabens, bisphenol A (BPA) and triclosan (TCS), used in awide variety of consum-
er products, are suspected endocrine disrupters although their level of toxicity is thought to be low. Combined
exposure may occur through ingestion, inhalation and dermal exposure, and their toxic as well as combined
effects are poorly understood.
The objective of the studywas to estimate the exposure to these chemicals in Swedishmothers and their children
(6–11 years old) and investigate potential predictors of the exposure. Urine samples from 98 mother–child
couples living in either a rural or an urban area were analyzed for the concentrations of four metabolites of di-
(2-ethylhexyl) phthalate (DEHP), three metabolites of di-iso-nonyl phthalate (DiNP), mono-ethyl phthalate
(MEP), mono-benzyl phthalate (MBzP) and mono-n-butyl phthalate (MnBP), methylparaben (MetP),
ethylparaben (EthP), propylparaben (ProP), butylparaben, benzylparaben, BPA, and TCS. Information on
sociodemographics, food consumption habits and use of personal care products, obtained via a questionnaire,
was used to investigate the associations between the urinary levels of chemicals and potential exposure factors.
Therewere fairly good correlations of biomarker levels between themothers and their children. The children had
generally higher levels of phthalates (geometric mean ΣDEHP 65.5 μg/L; ΣDiNP 37.8 μg/L; MBzP 19.9 μg/L;MnBP
76.9 μg/L) than the mothers (ΣDEHP 38.4 μg/L; ΣDiNP 33.8 μg/L; MBzP 12.8 μg/L; MnBP 63.0 μg/L). Conversely,
the mother's levels of parabens (MetP 37.8 μg/L; ProP 13.9 μg/L) and MEP (43.4 μg/L) were higher than
the children's levels of parabens (MetP 6.8 μg/L; ProP 2.1 μg/L) and MEP (28.8 μg/L). The urinary levels of low
molecular weight phthalates were higher among mothers and children in the rural area (MBzP p = b0.001;
MnBP p = 0.001–0.002), which is probably due to higher presence of PVC in ﬂoorings and wall coverings in
this area, whereas the levels of parabens were higher among the children in the urban area (MetP p = 0.003;
ProP p= 0.004) than in the rural area. The levels of highmolecular weight phthalates were associatedwith con-
sumption of certain foods (i.e. chocolate and ice cream) whereas the levels of parabens were associatedwith use
of cosmetics and personal care products.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).l A; BBzP, butylbenzyl phthal-
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Chemicals such as phthalates, parabens, bisphenol A (BPA) and
triclosan (TCS), used in a wide variety of consumer products, are
suspected endocrine disrupters although their level of toxicity is
thought to be low. Combined exposure may occur through ingestion,
inhalation and dermal exposure, and their toxic as well as combined
effects are poorly understood.
Phthalates are industrial chemicalswhich are used for awide range of
applications. They are primarily used as plasticizers in PVC found in con-
sumer products such as shoes, gloves and packingmaterials as well as in
building materials, ﬂoorings and wall coverings. Some phthalates arethe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
324 K. Larsson et al. / Environment International 73 (2014) 323–333also used in non-plastic products such as pharmaceuticals, personal care
products, paints and adhesives (Frederiksen et al., 2007;Wittassek et al.,
2011). Phthalates can be released from products and exposure may
occur in humans through food, dust, air and direct use of personal care
products (Janjua et al., 2008; Wittassek and Angerer, 2008; Wormuth
et al., 2006). After absorption, the parent phthalates are metabolized
into respectivemonoesters, which can be further hydroxylated, oxidized
and/or glucuronidated before excretion in urine as free or conjugated
monoesters (Frederiksen et al., 2007). The presence of phthalate metab-
olites in urine indicates recent exposure to respective parent compound
(Townsend et al., 2013). Some phthalates, such as di-(2-ethylhexyl)
phthalate (DEHP), butylbenzyl phthalate (BBzP) and di-n-butyl phthal-
ate (DnBP) are endocrine disrupters. These phthalates have been
shown in animal studies to affect the development of the reproduction
system inmale offspring, referred to as the “phthalate syndrome” includ-
ing e.g. shortened anogenital distance, hypospadias and cryptorchidism
(Foster, 2006; Gray et al., 2000; Mylchreest et al., 2000). Similar effects
have been observed after in utero exposure in humans (Suzuki et al.,
2012; Swan et al., 2005). Due to their supposed toxic effects, DEHP,
BBzP andDnBPhave been prohibitedwithin the EU from theproduction
of toys, childcare articles (EC, 2005) and cosmetic products (EC, 2009)
and the migration levels from food contact materials are regulated
(EC, 2007). Di-iso-nonyl phthalate (DiNP) is prohibited only from toys
which can be put in the mouth by the child (EC, 2005).
BPA (2,2-bis(4-hydroxyphenyl)propane) is a high production vol-
ume chemical used in polycarbonate plastics and epoxy resins, which
are used in e.g. CDs andDVDs, toothﬁllings, cash receipts, plastic bottles,
inner coatings of cans, and relining of water pipes. Food is the main
source of exposure in humans because BPA can migrate from cans
coated with epoxy as well as other plastics in contact with food or bev-
erages (Geens et al., 2012). In addition, BPA has been detected in indoor
dust which may contribute to the exposure (Geens et al., 2009;
Loganathan andKannan, 2011). After ingestion, BPA is readily absorbed,
glucuronidated or sulfatated and subsequently excreted in urine with
an elimination half-life of less than 6 h (Völkel et al., 2002). The levels
of BPA in spot-urine samples reasonably reﬂect the ongoing average ex-
posure on a population/group level (Christensen et al., 2012; Ye et al.,
2011). BPA is a well-known endocrine disruptor with estrogenic poten-
cy. The toxicity of BPA shown in animal studies has mainly been attrib-
uted to effects on the development and function of the reproductive
organs as well as the nervous system and behavior (Richter et al.,
2007). However, the low-dose effects shown for BPA are debated
(Beronius et al., 2010). Aiming to lower the exposure, the use of
BPA in baby bottles and cosmetics has been banned within the EU (EC,
2009, 2011).
Parabens are used as antimicrobial preservatives in personal
care products, cosmetics and pharmaceuticals. The maximum level of
parabens in cosmetics is restricted by the European Cosmetic Direc-
tive to 0.4% for one ester and 0.8% for a mixture of esters (EC, 2009).
Methylparaben (MetP), ethylparaben (EthP) and propylparaben
(ProP) are also permitted as food preservatives in confectionary and
dried meat (EC, 1995). Parabens are readily absorbed orally and to a
lesser extent dermally. After absorption, parabens can be hydrolyzed
to parahydroxybenzoic acid (PHBA) and/or conjugated and are then ex-
creted in urine as free or conjugated parabens and PHBA within hours
(Janjua et al., 2008; Ye et al., 2006a). Despite their short half-life, the
levels of parabens in a spot urine sample reasonably represent an
individual's exposure over several months (Smith et al., 2012). The
use of parabens has raised concern due to their weak estrogenic activity
conﬁrmed in in vivo and in vitro studies. The potency seems to increase
with the length of the alkyl chain, thus the long-chain parabens (e.g.
ProP and butylparaben (ButP)) are of highest concern (Boberg et al.,
2010; Routledge et al., 1998; Witorsch and Thomas, 2010). In 2010,
the EU Scientiﬁc Committee on Consumer Safety (SCCS) evaluated the
safety of parabens and concluded that the use of MetP and EthP below
the maximum permitted levels is considered safe, whereas the safetyof ProP and ButP at the maximum levels is more uncertain due to lack
of data (SCCS, 2011).
TCS (5-chloro-2-(2,4-dichlorophenoxy)phenol) is used as an anti-
microbial agent in personal care products such as deodorants, tooth-
pastes, mouth washes and shower gels, and also in consumer products
such as cleaning products, plastics and toys (Bedoux et al., 2012). TCS
is approved by the European Cosmetic Directive for use in cosmetic
products in concentrations up to 0.3% (EC, 2009), but is no longer per-
mitted for use in food contact materials (EC, 2010). TCS is readily
absorbed by the gastrointestinal tract, whereas the uptake via the oral
cavity and skin is lower (SCCP, 2009). After absorption, TCS is almost
completely converted to glucuronic and sulphuric acid conjugates and
is subsequently excreted predominately in urine as glucuronide conju-
gates. The elimination half-life in humans after oral administration is
estimated to be 13–29 h (SCCP, 2009). Serial measurements of TCS in
morning urine have shown relatively high consistency over time
(ICC = 0.56; (Lassen et al., 2013)). TCS has been shown in animal
studies to cause endocrine effects, especially on the levels of thyroid
hormones (Crofton et al., 2007; Dann and Hontela, 2011; Kumar et al.,
2009; Zorrilla et al., 2009). The Scientiﬁc Committee on Consumer Prod-
ucts (SCCP) has concluded that the current maximum concentration of
0.3% is not safewhen the aggregate exposure from all cosmetic products
is considered. However, the maximum concentration is considered safe
for individual products such as toothpastes, soaps and deodorants, but
not in products that stay on the skin (e.g. body lotions) or mouth
wash (SCCP, 2009).
The objectives of the present study were to evaluate the levels of 10
phthalate metabolites, 5 parabens, BPA and TCS in urine from Swedish
children (6–11 years old) and their mothers, in relation to demo-
graphics, lifestyle, housing and different potential sources of exposure
to these chemicals. The study is part of a harmonized approach for
biomonitoring on the European level; the COPHES (COnsortium to Per-
form Human biomonitoring on a European Scale) and DEMOCOPHES
(DEMOnstration of a study to COordinate and Perform Human biomon-
itoring on a European Scale) twin projects.
2. Materials and methods
2.1. Recruitment and sampling
The participants were selected via inhabitant registers, based on the
age of the child (6–11 years) and the living area. Themother–child cou-
ples were either from the urban area of Uppsala with a population of
140,000 inhabitants, or a sparsely populated area in the county of
Västerbotten in northern Sweden. Inclusion criteria included that the
mother was under 45 years of age, had lived in the study area for at
least 3 years, that the child lived more than half of the time at the
mother's address, and that the mother or child had no chronic kidney
or liver disease. The sampling was performed according to the harmo-
nized approach developed within the COPHES/DEMOCOPHES projects
(Becker et al., 2014). First morning urine samples were collected in
polypropylene tubes. The urine samples were frozen at −20 °C and
transported to the analyzing laboratories for analysis. Ethical permis-
sion was granted by the regional ethical review board in Stockholm
(Dnr 2011/1024-31/1).
2.2. Questionnaires
The mothers answered an extensive questionnaire (developed by
the COPHES/DEMOCOPHES consortium) covering questions about liv-
ing environment, food consumption, use of personal care products,
smoking, lifestyle and sociodemographics. The questionnaires were an-
swered through face-to-face interviews with ﬁeld workers or online.
The Computer Assisted Personal Interviewing system SOCRATOS
(Ivox, Belgium) was used for interviews and self-administered ques-
tionnaires. The information reported through questionnaires was
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further analysis. Also, a non-responder questionnaire was answered
by 65 mothers who chose to not participate in the full study.2.3. Chemical analysis
Urine samples from 98 mother–child couples were analyzed for
phthalates and BPA and 79 samples from mothers and 80 samples
from children were analyzed for parabens and TCS. Creatinine was
analyzed by the Jaffe method (Larsen, 1972). We participated in
the extensive analytical quality control program implemented by
COPHES/DEMOCOPHES for phthalates and BPA, with excellent re-
sults (Schindler et al., 2013).2.3.1. Phthalate metabolites
The urine samples were prepared with an automated solid-phase
extraction technique and analyzed by liquid chromatography tandem
mass spectrometry (LC/MS/MS) as previously described by Toft et al.
(2012), but with addition of DiNP metabolites. Moreover, in order to
reduce the contamination from the mobile phase a column was placed
in the ﬂow before the auto-samples. Brieﬂy, the samples were spiked
with internal standards for all analyzed metabolites, treated with
glucuronidase to hydrolyze glucuronic acid and acidiﬁed. The metabo-
lites were extracted using Oasis HLB 3 mL (60 mg) on an Aspec XL4
automated solid phase extraction equipment (Gilson; Middleton,
WI, USA). The samples were then evaporated and dissolved in a
water:acetonitrile solution (50:50) containing acetic acid and analyzed
by LC/MS/MS (Perkin-Elmer series 200; API 3000; Sciex, Framingham,
MA, USA). The limit of detection (LOD) was ≤0.1 μg/L for most of the
compounds but for MEP and MnBP it was 0.4 and 0.6, respectively.
The limit of quantiﬁcation (LOQ) was set to three times the detection
limit. The relative standard deviations (RSD) determined from analyses
of an in-house prepared chemical quality control sample,made by addi-
tion of small amounts of the metabolites to human urine and analyzed
two times within a sample batch of 50 samples, were b20% for all
metabolites analyzed; mono-ethyl phthalate (MEP; 460 μg/L) 15%,
mono-n-butyl phthalate (MnBP; 17 μg/L) 13%, mono-benzyl phthalate
(MBzP; 54 μg/L) 15%, mono(2-ethylhexyl)phthalate (MEHP; 41 μg/L)
11%, mono(2-ethyl-5-hydroxy-hexyl)phthalate (5-OH-MEHP; 84 μg/L)
16%, mono(2-ethyl-5-oxo-hexyl)phthalate (5-oxo-MEHP; 38 μg/L) 12%,
mono(2-ethyl-5-carboxy-pentyl)phthalate (5-cx-MEPP; 61 μg/L) 14%,
mono-(hydroxyl-isononyl)phthalate (OH-MiNP; 27 μg/L) 15%, mono-
(oxo-isononyl)phthalate (oxo-MiNP; 20 μg/L) 19%, and mono-(carboxy-
isooctyl)phthalate (cx-MiNP; 21 μg/L) 9%. All sample batches were
analyzedduring a period of amonth. The sampleswere analyzed in dupli-
cates and four chemical blank samples were included in all analytical
batches containing about 50 samples each.2.3.2. BPA
The analysis of BPA in urine was performed by LC/MS/MS according
to amodiﬁedmethod byKuklenyik et al. (2003) andVölkel et al. (2005).
Brieﬂy, urine was spiked with D16-labeled BPA as internal standard and
treated with glucuronidase (E-coli) to hydrolyze glucuronic acid. The
BPA was extracted using 3 mL SPE columns (EC) 221-0020-BPS (Sor-
bent) on the Aspec XL4. The analysis was performed on a LC/MS/MS
(Perkin-Elmer; series 200 LC and a Sciex API 3000 MS). The LOD was
0.05 μg/L and the LOQwas 0.15 μg/L. The RSD for the in-house prepared
quality control sample, made by addition of a small amounts of BPA to
human urine and analyzed two times within a sample batch of 50
samples, were 7% at 2 μg/L. All sample batches were analyzed during a
period of a month. The samples were analyzed in duplicates and two
chemical blank samples were included in all analytical batches contain-
ing about 50 samples each.2.3.3. Parabens and TCS
An on-line SPE-HPLC-MS/MS method (Ye et al., 2006b) was
adapted for ofﬂine use. An internal standard solution containing
500 ng/mL 13C6-propylparaben (Sigma-Aldrich, Steinheim, Germany),
and 500 ng/mL 13C12-triclosan (Wellington Laboratories, Ontario,
Canada) was prepared in methanol (MeOH, Rathburn, Scotland).
20 mg sulfatase (Helix pomatia, 15,000 U/g solid, Sigma-Aldrich)
was dissolved in 10 mL 1 M ammonium acetate buffer, pH 5. β-
Glucuronidase, type H-3AF (Helix pomatia 101,700 U/mL, Sigma-
Aldrich) was diluted ten times with water (MilliQ academic puriﬁer,
Millipore).
To 500 μL urine sample (or water for blanks), 10 μL internal standard
solution, 50 μL sulfatase solution and 50 μL glucuronidase solution were
added. After 4 h in 37 °C, 800 μL 0.1M formic acid was added. A SPE col-
umn (Isolute C18 100 mg, 3 mL, Biotage) was conditioned with 5 mL
MeOH and 5mLwater. The urine solutionwas added to the SPE column
and allowed to pass followed by 2 mL water. The column was dried by
applying suction for 5 min. The column was then eluted using 3 mL
MeOH. The volume of the eluate was reduced to approximately 0.5 mL
under a stream of nitrogen. A mixed calibration standard (5 μg/mL
of each compound in MeOH) was prepared from MetP (Supelco,
Bellefonte, PA, USA), EthP, ProP, ButP, and benzylparaben (BenP)
(Sigma-Aldrich), all with a declared purity of≥99%, and TCS (Ciba). Cal-
ibration solutions containing 10 μL internal standard solution and 0.01,
0.03, 0.1, 0.3, 1, 3, 10 ng calibration standard per mL were prepared in
MeOH. Calibration curves were run at the beginning, middle and end
of all sample batches. The calibration curves were linear including the
highest point corresponding to a maximum sample concentration of
20 ng/mL (500 μL urine used). Samples with higher concentrations
were re-run after dilution (maximum 1:20) or re-analyzed using a
smaller sample volume.
Liquid chromatography was performed on a Prominence UFLC sys-
tem (Shimadzu) with two pumps LC-20AD, degasser DGU-20A5,
autosampler SIL-20ACHT, analytical column (Thermo HyPurity C8
50 mm × 3 mm, particle size 5 μm; Dalco Chromtech) and column
oven CTO-20AC. The mobile phase A was 2 mM ammonium acetate in
water, and the mobile phase B was MeOH. The column temperature
was 35 °C and the ﬂow rate was 0.4 mL/min. The injection volume
was 10 μL and a gradient from 15% to 95% B was run for a total runtime
of 17 min. The efﬂuent was directed to an API 4000 triple quadrupole
mass spectrometer (Applied Biosystems) using electrospray ionization
in negative mode. Two different MRM transitions for each compound
were recorded and used as quantiﬁer and qualiﬁer, respectively. One
duplicate and one blank sample were analyzed for every eight urine
sample. The variation coefﬁcients (quadratic means for ﬁve samples an-
alyzed in duplicate) were 3.3%, 1.7%, 2.0%, 14%, 8.8% and 4.7% for MetP,
EthP, ProP, ButP, BenP and TCS, respectively. The sampleswere analyzed
during two sessions within a period of two months. For MetP, the LOD
was 1/1.4 μg/L (in two separate analytical runs) and the LOQ was
3.3/4.6 μg/L. For ProP, the LOD was 0.4/1.6 μg/L (in two separate an-
alytical runs) and the LOQ was 1.3/5.3 μg/L. For EthP, ButP, BenP and
TCS, the LOD and LOQ were 0.4 μg/L and 1.3 μg/L, respectively.
2.4. Statistical analysis
Urine samples with creatinine levels lower than 30 mg/dL or higher
than 300 mg/dL were excluded from the analysis (WHO, 1996).
Biomarker levels below the respective LOD were substituted by half
the value of LOD.
The statistical software IBM SPSS version 20 was used for the statis-
tical analyses. The levels of biomarkers in urine were not normally dis-
tributed and therefore logarithmic (ln)-transformed values were used
for the univariate and multiple analyses. Questionnaire variables with
multiple answer alternatives were categorized into two or three sub-
groups. Variables were excluded from the analysis if any subgroup
contained less than 5 participants. The studied variables were age,
326 K. Larsson et al. / Environment International 73 (2014) 323–333gender (only children), time since last urination (hours), living area
(urban/rural), education (highest in the family), recent renovation or
redecoration at home (within the last 2 years), PVC in ﬂoorings or
wall coverings, food consumption within the last 4 weeks (frequencies
of meat, ﬁsh, fast food,milk, cheese, chocolate, ice cream, chewing gum,
canteen food and canned food consumption), consumption of fast food
within the last 24 h, drinking water source (private well/public water
supply), use of personal care products (frequencies of lotion, skin
make-up, eye make-up, sunscreen, hair styling products, deodorant,
fragrance, shampoo, mouth wash and hand or body disinfectant),
playing with rubber-like plastic toys (frequency, only children) and
use of rubber gloves (frequency, only mothers).
The univariate comparisons between subgroups for each variable
were performed with analysis of variance (ANOVA) with a signiﬁcance
level of 0.05. Univariate analyses were performed with both raw and
creatinine-adjusted concentrations using ANOVA as well as with raw
values adjusted for creatinine and/or age using ANCOVA. In this article,
the results from the ANOVA with creatinine-adjusted levels of bio-
markers are presented. Multiple regression models for unadjusted
levels of each biomarker were created by forcing creatinine and age
into the models and applying stepwise selection of variables which
were correlated with respective biomarker below a signiﬁcance level
of 0.25 in the ANOVA analysis. Variables with a signiﬁcance level
below0.05were allowed to stay in theﬁnalmodel. The variable describ-
ing the overall use of personal care products was not included in the
multiple models due to high correlation with individual products. Uni-
variate and multiple analyses were not performed if the levels of the
biomarker were lower than the LOD in more than 50% of the samples.
The sum of DEHP metabolites (MEHP, 5-OH-MEHP, 5-oxo-MEHP
and 5-cx-MEPP) as well as the sum of DiNP metabolites (OH-MiNP,
oxo-MiNP and cx-MiNP) were calculated and used in the univariateTable 1
Levels of phthalatemetabolites, BPA, parabens and TCS in urine from Swedishmothers and child
and P95 are given for unadjusted and creatinine-adjusted levels of biomarkers. GM, P25 and P
Mothers
Parent
compound
Measured
biomarker
Unit n NLOD GM (95% CI) P25
DEHP MEHP μg/L 95 97.9% 2.32 (1.85–2.92) 1.34
μg/g creatinine 2.22 (1.85–2.68) 1.41
5-OH-MEHP μg/L 95 100% 14.94 (12.66–17.64) 9.65
μg/g creatinine 14.08 (12.25–16.18) 9.37
5-oxo-MEHP μg/L 95 100% 8.68 (7.34–10.28) 6.07
μg/g creatinine 8.18 (7.11–9.42) 5.27
5-cx-MEPP μg/L 95 100% 11.53 (9.79–13.59) 6.93
μg/g creatinine 10.87 (9.50–12.42) 6.79
BBzP MBzP μg/L 95 100% 12.81 (10.23–16.04) 5.72
μg/g creatinine 12.07 (9.99–14.58) 6.28
DnBP MnBP μg/L 95 100% 63.01 (53.63–74.04) 36.6
μg/g creatinine 59.36 (52.58–67.03) 37.7
DEP MEP μg/L 95 100% 43.40 (34.60–54.46)⁎ 18.0
μg/g creatinine 40.89 (33.17–50.41) 18.8
DiNP cx-MiNP μg/L 95 100% 19.74 (14.89–26.17) 6.79
μg/g creatinine 18.60 (14.20–24.37) 7.30
OH-MiNP μg/L 95 100% 8.33 (6.22–11.15) 3.32
μg/g creatinine 7.85 (5.93–10.37) 3.02
oxo-MiNP μg/L 95 100% 4.85 (3.68–6.40) 1.89
μg/g creatinine 4.57 (3.52–5.93) 1.77
BPA BPA μg/L 95 100% 1.31 (1.13–1.52) 0.80
μg/g creatinine 1.23 (1.09–1.41) 0.79
MetP MetP μg/L 76 100% 38 (26–55)⁎ 11
μg/g creatinine 36 (25–53)⁎ 11
EthP EthP μg/L 76 94.7% 3.1 (2.1–4.6)⁎ 0.89
μg/g creatinine 3.0 (2.0–4.4)⁎ 0.79
ProP ProP μg/L 76 88.2% 14 (8.8–22)⁎ 3.5
μg/g creatinine 13 (8.5–21)⁎ 2.5
ButP ButP μg/L 76 36.8% – –
μg/g creatinine – –
TCS TCS μg/L 76 36.8% – –
μg/g creatinine – –
⁎ Mothers/children have statistically signiﬁcant (p b 0.05) higher levels of the biomarker.and multiple analyses. Analyses of the correlation between different
metabolites in the same sample as well as the correlation of biomarkers
between themothers and their childrenwere performed using the non-
parametric Spearman's correlation (rs) test.
A non-responder analysis was performed based on the 98 mothers
who participated in the study and 65 mothers who had answered the
non-responder questionnaire, but did not participate in the study.
Pearson Chi-square test was used to evaluate signiﬁcant (p b 0.05)
differences in civil status, smoking status, education and work status.
3. Results
In total, 98 mother–child pairs were recruited. After exclusion of
samples with creatinine levels below 30 mg/dL or above 300 mg/dL
and one sample that was not ﬁrst morning urine, 95 mothers and 97
children were included in the analyses. Among the children there
were 47 boys and 50 girls, 47 were living in the urban area and 50
were living in the rural area. The response rate was 22%. However, the
non-responder analysis did not show any signiﬁcant differences
between participating and non-participating mothers regarding civil
status, smoking status, education and work status.
The creatinine levels were signiﬁcantly lower in the children
(94 mg/dL) than in the mothers (114 mg/dL) and the levels of creati-
nine in urinewere signiﬁcantly positively correlated with the children's
age (Spearman's correlation coefﬁcient; rs = 0.27; p = 0.006).
3.1. Phthalates
The phthalate metabolites were detected at levels above the LOD
in all urine samples, except for MEHP which was detected in 98% of
the urine samples from themothers (Table 1). The children generallyren. Geometricmean (GM)with 95% conﬁdence interval (95% CI) and percentiles P25, P50
50 are not given if more than 50% b LOD.
Children
P50 P95 n NLOD GM (95% CI) P25 P50 P95
2.64 8.05 97 100% 2.74 (2.30–3.26) 1.44 2.87 12.81
2.40 9.11 3.08 (2.60–3.64)⁎ 1.72 3.19 11.47
13.40 50.62 97 100% 24.56 (21.34–28.28)⁎ 14.27 24.50 125.05
13.17 39.00 27.75 (24.36–31.60)⁎ 17.00 26.69 93.50
8.04 28.73 97 100% 15.68 (13.57–18.11)⁎ 9.25 16.34 72.65
7.34 28.54 17.71 (15.51–20.21)⁎ 10.58 17.74 60.54
10.69 50.30 97 100% 21.54 (18.77–24.71)⁎ 13.24 22.77 78.07
10.04 36.11 24.33 (21.31–27.78)⁎ 14.10 23.12 82.01
12.56 86.02 97 100% 19.91 (16.79–23.61)⁎ 10.00 22.17 80.51
10.83 74.16 22.49 (18.80–26.89)⁎ 11.53 22.37 96.58
9 59.19 296.27 97 100% 76.87 (68.11–86.75)⁎ 52.36 79.25 192.67
9 58.49 161.19 86.83 (76.72–98.26)⁎ 65.80 83.24 236.58
9 42.40 328.55 97 100% 28.83 (23.73–35.01) 15.62 24.68 201.55
5 36.97 320.82 32.56 (27.12–39.10) 19.44 27.36 179.08
15.55 332.68 97 100% 21.66 (17.55–26.72) 11.34 19.89 215.67
13.51 290.09 24.46 (19.54–30.63)⁎ 12.14 21.41 231.59
6.54 148.04 97 100% 9.72 (7.89–11.97) 4.95 8.95 56.67
5.61 180.74 10.98 (8.81–13.69)⁎ 5.05 9.73 73.23
3.87 59.11 97 100% 5.63 (4.61–6.89) 2.91 5.19 41.25
3.35 74.61 6.36 (5.15–7.86)⁎ 3.06 5.46 44.27
1.29 5.02 97 100% 1.48 (1.27–1.73) 0.90 1.31 6.24
1.20 3.95 1.67 (1.43–1.95)⁎ 1.00 1.46 6.30
40 680 80 86.2% 6.8 (4.6–10) 1.9 5.3 220
40 625 7.5 (5.1–11) 2.6 5.5 240
2.4 84 80 77.5% 0.77 (0.59–1.0) 0.42 0.66 8.6
2.4 70 0.85 (0.64–1.1) 0.41 0.77 8.8
18 280 80 62.5% 2.1 (1.4–3.1) – 1.9 49
14 220 2.3 (1.6–3.4) – 2.1 50
– 11 80 13.8% – – – 0.84
– 9.7 – – – 0.87
– 7.3 80 36.3% – – – 4.5
– 16 – – – 3.7
Table 2
Correlations between creatinine-adjusted levels of phthalate metabolites, BPA, parabens
and TCS in samples from mothers (gray) and children (white). Spearman's correlation
coefﬁcient is presented.
ΣDEHP ΣDiNP MEP MBzP MnBP BPA MetP EthP ProP TCS
ΣDEHP 0.37** −0.07 0.33** 0.22* 0.35** 0.03 0.08 −0.05 0.13
ΣDiNP 0.51** −0.12 0.00 −0.08 0.05 0.00 −0.05 0.02 −0.04
MEP 0.10 0.09 0.06 0.06 0.03 0.09 0.03 0.22 0.21
MBzP 0.45** 0.32** 0.16 0.53** 0.17 −0.03 0.06 −0.07 0.09
MnBP 0.29** 0.16 0.34** 0.48** 0.06 0.03 0.17 −0.00 −0.02
BPA 0.45** 0.16 0.13 0.18 0.13 0.10 −0.01 −0.04 0.14
MetP 0.14 0.06 0.11 −0.07 0.18 0.13 0.38** 0.81** 0.11
EthP 0.16 0.14 0.02 0.03 0.13 0.14 0.45** 0.24* 0.10
ProP 0.21 0.11 0.12 0.04 0.12 0.17 0.69** 0.40** 0.04
TCS 0.15 0.03 0.11 0.19 0.27* 0.14 0.01 0.23* 0.08
*Correlation is signiﬁcant at the 0.05 level (2-tailed).
**Correlation is signiﬁcant at the 0.01 level (2-tailed).
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lites, except for MEP which was higher in the mothers. There were
strong correlations between the levels of individual DEHP metabo-
lites (rs = 0.60–0.96; p b 0.001) as well as between individual
DiNP metabolites (0.88–0.96; p b 0.001) in urine (Table 2). ThereTable 3
Geometric mean levels (μg/g creatinine) of biomarkers in mothers categorized by populatio
indicated by bold script and asterisks (*p b 0.05, **p b 0.01, ***p b 0.001). Variables which we
Variable Na Nb Category DEHP
Age 21 17 b37 years 36.63
43 31 38–40 years 32.02
31 28 N41 years 40.52
Area 46 39 Urban 37.26
49 37 Rural 35.20
Education 24 17 High school/college 33.95
70 59 University/PhD 37.04
House renovation/redecoration last 2 yrs 58 45 Yes 35.16
37 31 No 37.83
PVC in ﬂoorings or wall coverings at home 36 30 Yes 34.99
31 24 No 39.65
Meat consumption 77 63 Several times per week 34.71
18 13 Once a week or less 43.16
Fish consumption 35 31 Several times per week 39.45
60 45 Once a week or less 34.40
Chocolate consumption 41 35 Several times per week 44.52
53 40 Once a week or less 30.85
Fast food consumption 8 7 Several times per week 38.63
87 69 Once a week or less 35.95
Chewing gum consumption 34 30 Several times per week 34.30
60 46 Once a week or less 37.37
Canteen food consumption 38 32 Several times per week 32.10
55 42 Once a week or less 38.21
Drinking water 87 71 Public water supply 36.31
8 5 Well/private water 34.88
Use of rubber gloves 25 21 Daily or sometimes 34.74
68 55 Never 36.93
Number of personal care products 63 50 High amount 33.05
27 22 Moderate amount 43.47
Lotion 78 65 Every second day or more 36.31
16 10 Once a week or less 33.52
Skin Make-up 62 50 Daily use 34.30
33 26 Every second day or less 40.00
Eye make-up 70 56 Daily use 32.82
25 20 Every second day or less 47.51
Sunscreen 12 7 Once a week or more 43.40
79 65 Seldom/never 34.70
Mouth wash 12 11 Every second day or more 35.09
83 65 Once a week or less 36.34
a Number of samples analyzed for phthalates and BPA.
b Number of samples analyzed for parabens.
c Sum of MEHP, 5-OH-MEHP, 5-oxo-MEHP and 5-cx-MEPP.
d Sum of OH-MiNP, oxo-MiNP and cx-MiNP.was also a signiﬁcant correlation between the sum of DEHP metab-
olites and the sum of DiNP metabolites. Also, the levels MnBP and
MBzP were well correlated, whereas MEP had the weakest correla-
tion to the other phthalate metabolites. There were statistically sig-
niﬁcant correlations of all phthalate metabolites in urine from the
mothers and their children (rs = 0.24–0.62; p = b0.001–0.03), ex-
cept for cx-MiNP (rs = 0.17; p = 0.10), both for unadjusted (rs
within parentheses) and creatinine adjusted concentrations (data
not shown). The strongest mother–child correlation was seen for
MBzP (rs = 0.62).
Signiﬁcant exposure variables, as evaluated by the univariate analy-
sis, in mothers and children are presented in Tables 3 and 4, respective-
ly. Living in the rural areawas associatedwith signiﬁcantly higher levels
of MBzP, MnBP and MEP in mothers and children compared to living in
the urban area. Living in a house with PVC in ﬂoorings or wall coverings
was associatedwith higher levels ofMBzP in bothmothers and children,
and also MnBP in children. Children and mothers from families with
low education had higher levels of MBzP and children from these
families also had higher levels of MnBP and MEP. Younger children
(6–8 years) had higher levels of MnBP, DEHP and DiNP metabolites
than older children (9–11 years). However, if raw levels of phthalate
metabolites were used in the analysis instead of creatinine-adjusted
levels, only DiNP remained signiﬁcantly associated with age (data notn characteristics and potential exposure sources. Statistically signiﬁcant differences are
re not signiﬁcantly correlated with any biomarker are not included in the table.
c MEP MBzP MnBP DiNPd BPA MetP EthP ProP
44.04 15.88* 58.95 34.15 1.01 35.64 3.13 16.31
39.08 11.79 66.99 32.01 1.23 28.38 2.57 8.45
39.69 9.32 52.78 29.57 1.52* 45.27 3.29 16.61
31.45 6.74 46.03 41.03 1.31 45.75 3.03 17.50
52.33* 20.85*** 75.37*** 25.15 1.17 28.14 2.94 9.85
50.57 19.06** 67.02 33.58 1.11 40.32 5.99 10.56
38.68 10.18 56.17 31.82 1.27 34.98 2.44 14.11
48.62* 12.72 58.52 34.39 1.27 30.81 2.10 12.63
31.17 11.12 60.70 28.31 1.19 45.48 4.97* 14.14
41.73 17.47*** 63.65 27.28 1.28 31.24 1.65 13.26
50.66 7.49 53.43 33.17 1.33 53.67 3.90 16.80
39.88 11.77 58.78 27.42 1.13 33.20 3.02 12.26
45.51 13.42 61.93 60.76* 1.81** 54.29 2.83 19.08
38.06 10.94 56.65 38.50 1.52* 40.32 3.68 13.83
42.64 12.78 61.00 28.56 1.10 33.47 2.58 12.82
** 35.09 12.17 59.00 33.39 1.28 27.98 2.48 9.88
46.34 11.98 59.34 30.25 1.21 42.09 3.77 15.79
36.44 11.36 67.79 39.68 2.02* 52.74 1.06 14.98
41.33 12.14 58.64 31.24 1.18 34.75 3.32 13.06
52.40 10.05 56.44 39.35 1.15 65.24* 4.42 24.69*
36.25 13.18 60.11 28.82 1.28 24.55 2.31 8.80
38.45 8.52 51.79 39.15 1.12 37.64 2.80 15.18
43.60 15.20** 65.29 27.54 1.28 39.71 3.51 13.21
38.40 11.53 57.10 30.30 1.25 34.81 2.75 12.68
80.99 19.91 90.61* 55.40 1.12 60.77 9.71 24.07
51.08 13.70 59.82 43.63 1.39 63.36 2.32 32.87*
37.83 11.35 58.39 28.68 1.20 29.13 3.29 9.34
43.95 11.13 57.44 32.72 1.24 50.10** 3.11 19.42**
30.66 14.14 58.98 31.34 1.24 14.95 3.44 4.81
41.39 12.08 60.95 29.69 1.25 46.12*** 2.97 17.57**
40.00 12.06 53.18 39.01 1.07 6.59 3.53 2.26
42.05 10.41 56.80 36.00 1.23 56.73*** 3.15 24.64***
38.81 15.94* 64.50 25.38 1.24 15.15 2.70 4.00
41.88 10.47 56.94 32.73 1.17 43.16 2.97 19.54**
* 38.24 17.94* 66.71 29.63 1.42 21.92 3.03 4.43
86.21** 10.45 72.76 66.44 1.34 66.59 14.43* 27.17
35.39 12.03 57.30 29.77 1.22 35.80 2.59 12.75
25.62 7.05 52.16 64.16 1.01 93.70* 4.37 42.88*
43.75 13.04* 60.48 28.81 1.27 30.73 2.80 10.84
Table 4
Geometric mean levels of biomarkers (μg/g creatinine) in children categorized by population characteristics and potential exposure sources. Statistically signiﬁcant differences are indi-
cated by bold script and asterisks (*p b 0.05, **p b 0.01, ***p b 0.001). Variables which were not signiﬁcantly correlated with any biomarker are not included in the table.
Variable Na Nb Category DEHPc MEP MBzP MnBP DINPd BPA MetP ProP
Age 49 40 6–8 years 91.20*** 32.42 25.23 101.79** 57.37** 2.01* 11.35* 2.87
48 40 9–11 years 59.74 32.71 19.99 73.82 31.53 1.39 4.96 1.90
Area 47 40 Urban 75.09 25.18 13.72 67.63 41.41 1.77 13.01** 4.29**
50 40 Rural 72.94 41.46** 35.78*** 109.81*** 43.88 1.58 4.32 1.27
Education 24 19 High school/college 73.89 51.06** 33.77** 111.06* 47.26 1.78 6.76 1.24
72 61 University/PhD 74.00 27.92 19.41 78.88 40.42 1.64 7.75 2.85
PVC in ﬂoorings or wall coverings at home 35 30 Yes 73.08 37.96 27.90** 99.34* 39.93 1.71 7.89 1.89
32 26 No 77.24 28.72 16.46 67.67 43.36 1.63 7.82 2.57
Fast food consumption 9 8 Several times per week 81.06 25.36 32.05 69.43 89.38* 2.09 5.16 3.13
87 71 Once a week or less 72.70 33.47 21.73 89.31 39.56 1.63 7.78 2.26
Cheese consumption 66 56 Several times per week 72.96 33.89 25.01* 92.44 40.46 1.67 8.92 2.76
28 21 Once a week or less 72.53 28.52 16.64 74.86 46.86 1.66 4.64 1.43
Ice cream consumption 14 13 Several times per week 103.07* 25.73 24.58 66.36 74.53* 2.20 4.47 2.13
80 64 Once a week or less 69.77 33.78 22.42 92.29 38.94 1.60 8.42 2.41
Canteen food consumption 50 40 Daily 75.97 31.20 24.59 94.90 45.88 1.78 5.91 1.60*
46 40 Less than daily 72.66 34.56 19.93 79.37 40.69 1.55 9.51 3.42
Drinking water 88 74 Public water supply 73.90 31.45 21.23 83.34 41.72 1.64 7.02 2.43
9 6 Well/private water 74.70 45.74 39.51* 129.67* 53.08 2.04 17.04 1.47
Play with plastic toys 24 18 Daily 82.90 22.96* 28.60 97.65 38.26 1.69 5.31 1.77
53 45 Less than daily/never 66.67 35.76 19.88 82.52 42.65 1.64 8.58 2.61
Lotion 44 36 Once a week or more 76.22 30.10 20.05 90.78 39.59 1.69 13.54** 4.22**
52 43 Seldom/never 72.21 34.90 24.13 83.40 45.73 1.67 4.45 1.35
Eye make-up 6 5 Once a week or more 46.24 88.95** 18.77 92.43 16.26 2.14 11.06 5.91
90 74 Seldom/never 76.38 30.50 22.41 86.34 45.65* 1.65 7.19 2.13
Hair styling products 10 10 Once a week or more 81.78 22.17 17.17 51.98 52.07 1.83 4.99 3.29
86 69 Seldom/never 73.17 34.11 22.83 92.02** 41.84 1.66 7.82 2.15
Nail polish 8 8 Once a week or more 47.53 35.18 14.97 76.31 22.13 1.42 7.78 3.24
88 71 Seldom/never 77.06* 32.39 22.97 87.72 45.45 1.71 7.34 2.18
Deodorant 11 10 Every second day or more 64.28 46.04 16.13 57.98 29.34 1.57 13.68 3.81
85 69 Once a week or less 75.38 31.19 23.10 91.34* 44.95 1.69 6.76 2.20
Fragrance 5 5 Once a week or more 80.92 28.92 13.84 45.25 60.17 1.69 5.90 3.53
91 74 Seldom/never 73.66 32.83 22.75 89.86* 42.01 1.68 7.50 2.21
a Number of samples analyzed for phthalates and BPA.
b Number of samples analyzed for parabens.
c Sum of MEHP, 5-OH-MEHP, 5-oxo-MEHP and 5-cx-MEPP.
d Sum of OH-MiNP, oxo-MiNP and cx-MiNP.
328 K. Larsson et al. / Environment International 73 (2014) 323–333shown). The urinary levels of phthalates did not signiﬁcantly differ
between boys and girls.
In children, the univariate analysis of phthalates showed signiﬁcant
correlations with several dietary variables. DEHP and DiNP metabolites
were correlated with ice cream, DiNP metabolites with fast food and
MBzP with cheese. Among the mothers, DEHP metabolites were corre-
lated with chocolate consumption. Drinkingwater from a well was cor-
related with higher levels of MnBP in mothers and children, and also
MBzP in children compared to drinking water from a public water
supply.
The univariate analysis of personal care products showed signiﬁ-
cant correlations between urinary levels of MEP and the use of sun-
screen among mothers and the use of eye make-up among children
(Tables 3 and 4). Negative correlations were found between the
use of several personal care products and levels of MnBP, MBzP and
DEHP metabolites.
The multiple regression models for the children showed signiﬁcant
correlations between ice cream consumption and levels of DiNPmetab-
olites and between use of eyemake-up and levels of MEP (Table 5). Liv-
ing in the rural area was correlated to higher levels of MBzP and MnBP
in children. In the multiple regression models for the mothers, living in
the rural areawas correlatedwith higher levels ofMBzP,MnBP andMEP
andmothers living in houseswith PVC in ﬂoorings orwall coverings had
higher levels ofMBzP. Use of sunscreenwas correlated to higher urinary
levels of MEP and use of fragrance was correlated to higher levels of
DiNP metabolites in the mothers (Table 5). Mothers who frequently
consumed chocolate had higher levels of DEHP metabolites, whereas
negative correlations were found between meat consumption andlevels of DiNP metabolites and between canteen food consumption
and levels of MBzP.
3.2. Bisphenol A
Urinary BPA was detected in levels above the LOD in all urine sam-
ples (Table 1). The levels of BPA were signiﬁcantly correlated between
the mothers and their children (rs = 0.35; p = 0.001).
In the univariate analysis, mothers who often ate ﬁsh or fast food
had higher levels of BPA (Table 3). In the multiple models, there was
a negative correlation between mother's meat consumption and
BPA, whereas there was a positive correlation between children's
chocolate consumption and BPA (Table 5). Age was correlated to
the BPA levels in mothers and children in both the univariate and
multiple analyses. Younger children (6–8 years) had higher levels
compared to older children (9–11 years), whereas the oldest
mothers (N41 years) had higher levels than the youngest mothers
(b37 years).
3.3. Parabens
Among the parabens, MetP was detected in concentrations above
the LOD in 100% of the urine samples from mothers and in 86% of the
samples from children. EthP was detected in levels above the LOD in
95% of the samples from mothers and in 77% of the samples from chil-
dren. ProP was detected in concentrations above the LOD in 88% of the
samples from mothers and in 62% of the samples from children. ButP
was found in levels above the LOD only in 37% of the samples from
Table 5
Multiple regression models using ln-transformed levels of biomarkers, with creatinine (g/L) and age forced into the models. For individual variables, B-values are given with 95% conﬁ-
dence interval (95% CI) and p-value. For the full models, adjusted R2 and p-values are given.
Variable B (95% CI) p-Value Adjusted R2 (p-value) Variable B (95% CI) p-Value Adjusted R2 (p-value)
Mothers Children
DEHPa Intercept 2.55 (2.15–2.95) – 0.33 (b0.001) Intercept 3.00 (2.49–3.50) – 0.22 (b0.001)
Creatinine 0.91 (0.63–1.19) b0.001 Creatinine 1.03 (0.58–1.48) b0.001
b37 yearsc −0.13 (−0.47–0.21) 0.458 6–8 yearsd 0.43 (0.14–0.73) 0.004
38–40 yearsc −0.20 (−0.54–0.14) 0.252
Chocolate 0.31 (0.04–0.59) 0.028
DiNPb Intercept 2.74 (1.75–3.73) – 0.14 (0.003) Intercept 3.14 (2.39–3.88) – 0.06 (0.032)
Creatinine 0.86 (0.31–1.41) 0.002 Creatinine 0.20 (−0.46–0.86) 0.546
b37 yearsc 0.14 (−0.53–0.81) 0.681 6–8 yearsd 0.43 (0.00–0.86) 0.048
38–40 yearsc 0.16 (−0.52–0.83) 0.642 Ice cream 0.63 (0.05–1.21) 0.034
Meat −0.74 (−1.44 to−0.04) 0.040
Fragrance 0.56 (0.02–1.10) 0.042
MBzP Intercept 1.61 (0.95–2.26) – 0.58 (b0.001) Intercept 2.84 (2.10–3.58) – 0.23 (b0.001)
Creatinine 1.12 (0.76–1.48) b0.001 Creatinine 0.53 (−0.14–1.21) 0.117
b37 yearsc 0.07 (−0.38–0.52) 0.750 6–8 yearsd 0.18 (−0.25–0.60) 0.406
38–40 yearsc −0.17 (−0.63–0.28) 0.448 Urban area −0.90 (−1.31 to−0.48) b0.001
Urban area −0.78 (−1.21 to−0.35) b0.001
Canteen food −0.47 (−0.84 to−0.11) 0.012
PVC 0.48 (0.04–0.91) 0.031
MnBP Intercept 3.27 (2.81–3.72) – 0.47 (b0.001) Intercept 3.70 (3.21–4.18) – 0.21 (b0.001)
Creatinine 0.93 (0.65–1.22) b0.001 Creatinine 0.77 (0.33–1.21) b0.001
b37 yearsc −0.06 (−0.42–0.30) 0.734 6–8 yearsd 0.30 (0.02–0.58) 0.036
38–40 yearsc 0.12 (−0.24–0.47) 0.519 Urban area −0.46 (−0.73 to−0.19) 0.001
Urban area −0.47 (−0.77 to−0.17) 0.002
MEP Intercept 2.96 (2.32–3.59) – 0.29 (b0.001) Intercept 2.37 (1.49–3.25) – 0.15 (0.009)
Creatinine 0.81 (0.41–1.21) b0.001 Creatinine 0.91 (0.12–1.70) 0.025
b37 yearsc −0.14 (−0.64–0.36) 0.574 6–8 yearsd 0.13 (−0.39–0.64) 0.626
38–40 yearsc −0.25 (−0.76–0.25) 0.316 Eye make-up 1.19 (0.14–2.25) 0.028
Sunscreen 1.07 (0.47–1.67) b0.001
Urban area −0.68 (−1.10 to−0.26) 0.002
N8 h since urination 0.47 (0.07–0.88) 0.023
BPA Intercept −0.07 (−0.52–0.38) – 0.29 (b0.001) Intercept −0.53 (−1.08–0.03) – 0.10 (0.005)
Creatinine 0.73 (0.47–0.99) b0.001 Creatinine 0.73 (0.24–1.22) 0.004
b37 yearsc −0.37 (−0.69 to−0.05) 0.023 6–8 yearsd 0.32 (0.00–0.63) 0.050
38–40 yearsc −0.12 (−0.45–0.20) 0.445 Chocolate 0.41 (0.01–0.81) 0.047
Meat −0.42 (−0.76 to−0.08) 0.014
MetP Intercept 1.86 (0.72–3.01) – 0.23 (b0.001) Intercept −0.67 (−1.96–0.63) – 0.28 (b0.001)
Creatinine 0.22 (−0.50–0.93) 0.546 Creatinine 1.00 (−0.14–2.13) 0.085
b37 yearsc −0.05 (−0.89–0.79) 0.909 6–8 yearsd 0.77 (0.05–1.50) 0.037
38–40 yearsc −0.34 (−1.18–0.51) 0.430 Lotion 1.19 (0.49–1.89) 0.001
Skin make-up 1.19 (0.48–1.91) 0.001 Urban area 1.13 (0.39–1.88) 0.003
Lotion 1.01 (0.30–1.72) 0.006 Well water 1.69 (0.42–2.95) 0.010
Plastic gloves 0.83 (0.03–1.63) 0.042
EthP Intercept 0.41 (−0.64–1.47) – 0.10 (0.030) –
Creatinine 0.28 (−0.48–1.04) 0.466
b37 yearsc 0.00 (−0.93–0.94) 0.994
38–40 yearsc −0.23 (−1.17–0.71) 0.626
Sunscreen 1.65 (0.50–2.79) 0.005
Education low 1.01 (0.14–1.87) 0.023
ProP Intercept 0.76 (−0.49–2.01) – 0.26 (b0.001) Intercept −1.78 (−3.06 to−0.51) – 0.28 (b0.001)
Creatinine 0.36 (−0.47–1.20) 0.387 Creatinine 1.17 (0.02–2.33) 0.047
b37 yearsc 0.24 (−0.75–1.22) 0.633 6–8 yearsd 0.62 (−0.11–1.36) 0.096
38–40 yearsc −0.46 (−1.44–0.52) 0.354 Lotion 1.06 (0.36–1.76) 0.004
Skin make-up 1.76 (0.92–2.60) b0.001 Urban area 1.08 (1.80–0.37) 0.004
Plastic gloves 1.36 (0.43–2.30) 0.005 Eye make-up 1.61 (0.08–3.14) 0.039
a Sum of MEHP, 5-OH-MEHP, 5-oxo-MEHP and 5-cx-MEPP.
b Sum of cx-MiNP, oxo-MiNP and OH-MiNP.
c Compared to age group N41 years.
d Compared to age group 9–11 years.
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ed in any of the samples. The mothers had signiﬁcantly higher levels of
parabens than the children (Table 1). Due to the low number of samples
with concentrations of ButP and BenP above the respective LOD, univar-
iate and multiple analyses were not performed for these compounds.
Also, the levels of EthP in children were not normally distributed even
after ln-transformation, thus no further analysis of EthP among children
was performed. Among the parabens, the correlation betweenMetP and
ProP was the strongest, whereas the correlations between EthP and
MetP as well as between EthP and ProP were weaker (Table 2). Therewere signiﬁcant correlations between the levels in mothers and their
children of MetP (rs = 0.36; p = 0.002) and ProP (rs = 0.55; p =
b0.001), but not EthP (rs = 0.19; p = 0.09).
In the univariate analysis, mothers who used a high number of per-
sonal care products (make-up, shampoo, hair styling products, lotion,
fragrance, deodorant, massage oil and nail polish) had signiﬁcantly
higher levels of MetP and ProP (Table 3). Higher levels of MetP and
ProP were especially associated to the use of make-up, lotion and
mouth wash. The levels of EthP were higher in mothers who more fre-
quently used sunscreen. Among the children, the combined number of
330 K. Larsson et al. / Environment International 73 (2014) 323–333personal care products used was not signiﬁcantly correlated with the
levels of parabens. However, when the personal care products were
studied separately, signiﬁcant positive correlationswere foundbetween
the use of lotion and levels of MetP and ProP (Table 4). In mothers, fre-
quent chewing gum consumption was associated with higher levels of
MetP and ProP, and regular use of plastic gloves was associated with
higher levels of ProP (Table 3). Children living in the urban area had
higher levels of MetP and ProP than children living in the rural area
(Table 4).
In themultiple analysis among themothers, the use of skinmake-up
was correlated to higher levels of MetP and ProP, lotion was correlated
with MetP and sunscreen with EthP (Table 5). Regular use of plastic
gloves was correlated with higher levels of both MetP and ProP.
Among the children, the multiple analyses showed signiﬁcant correla-
tions between the use of lotion and higher levels of MetP and ProP,
and between the use of eye make-up and levels of ProP. Living in an
urban area was correlated to higher levels of MetP and ProP and
younger children had higher levels of MetP than older children. Also,
drinking water from a well was correlated with higher levels of MetP
(Table 5).
3.4. Triclosan
TCSwas detected in levels above the LOD in 37% of the samples from
mothers and 36% of the samples from children (Table 1). Due to the low
number of samples with TCS levels above the LOD, no univariate or
multiple analyseswere performed. However, it can be noted that no ob-
vious differences in TCS levels were detected between users and non-
users of products which may contain TCS, such as mouth-wash, hand
disinfectants or deodorants (data not shown). The levels of TCS were
signiﬁcantly correlated between the mothers and their children
(rs = 0.35; p = 0.001).
4. Discussion
We have evaluated the signiﬁcance of potential exposure sources
of phthalates, BPA, parabens as well as TCS in mothers and their chil-
dren (6–11 years old) in a rural and an urban area of Sweden. We
measured metabolites of these compounds in ﬁrst morning urine
and used a questionnaire to obtain information on potential expo-
sure sources and factors. In general, children had higher levels of
phthalate metabolites in urine than the mothers, except for a phthal-
ate metabolite associated with the use of cosmetics (MEP). The
mothers had higher levels of parabens associated with a frequent
use of cosmetic products. We found comparatively low levels of
BPA and TCS in urine.
PVC in the home environment is a strong predictor for exposure to
phthalates. Previous studies have shown that dust in houses with PVC
ﬂooring contains higher levels of BBzP and DEHP (Bornehag et al.,
2005) and that individuals living in houses with PVC in ﬂooring or
wall coverings have higher urinary levels of MBzP, the corresponding
metabolite to BBzP (Carlstedt et al., 2013). In the current study, PVC in
the home environment was associated with higher urinary levels of
MBzP and MnBP. Families living in the rural area and having lower
education were more likely to have PVC in their homes. Therefore, the
effect of PVC may explain why mother–child couples in the rural area
and with low education had higher levels of MnBP and MBzP.
Besides PVC in the home environment, phthalate exposure is associ-
ated with consumption of certain foods. Phthalates can be found in a
wide range of food groups on the retail market and previous studies
have shown that food is the main exposure source for high molecular
weight phthalates, whereas humans are exposed to low molecular
weight phthalates, such as BBzP, DnBP and diethyl phthalate (DEP),
from other sources than food, i.e. PVC plastics, paints and cosmetics
(Fierens et al., 2012; Fromme et al., 2007; Koch et al., 2013; Schecter
et al., 2013; Wittassek et al., 2011). In the present study, consumptionof ice cream among children and chocolate among mothers was signif-
icantly correlated with higher levels of urinary phthalate metabolites
originating from high molecular weight phthalates (DEHP and DiNP),
indicating migration of these phthalates into the food through the pro-
duction or packaging of food. Few studies have investigated the impor-
tance of speciﬁc foods for the dietary intake of phthalates. An American
study combining urinary levels of phthalates and 24 hour dietary recalls
ofmeat, poultry,ﬁsh, dairy and vegetable consumption found the stron-
gest correlations between urinary DEHP metabolites and consumption
of poultry as well as between urinary MEP and vegetable consumption
(Colacino et al., 2010). Sioen et al. (2012) performed an intake assess-
ment of phthalates in the Belgian population, using food consumption
data and phthalate concentrations in foods. The assessment showed
that bread was the major contributor to the DEHP intake in both adults
and children. Dietary intakes of phthalates in UK children and adults
have also been assessed in the UK Total Diet Study with food samples
collected in 2007 (Committee on Toxicity, 2011). The results showed
that the main contributors to the intake of DEHP were ﬁsh, meat,
poultry and dairy products.
Food is the main source of BPA exposure and associations between
BPA levels in urine and certain food habits were therefore expected. In
the current study, higher levels of BPA were found in children who
often ate chocolate, probably reﬂecting a more frequent consumption
of foods contaminated from food wrapping materials. The dietary BPA
exposure may depend more on the food packaging than the food item
per se, and especially canned foods are known to contain high levels
of BPA (Cao et al., 2011; Schecter et al., 2010). In the current study,
there was a tendency but no signiﬁcant association between consump-
tion of canned foods and BPA among women. However, the number of
mothers who reported frequent consumption of canned foods was
low (n = 8). The elevated levels of BPA in mothers who seldom or
never ate meat may be due to their relatively higher consumption of
other foods containing BPA. For example, the current study showed a
positive correlation between ﬁsh consumption and levels of BPA in
mothers. This association may be explained by consumption of canned
tuna, often used in sandwiches and salads, and which is common
among Swedish women. An association between urinary levels of BPA
in women of childbearing age and canned ﬁsh has previously been
demonstrated in a Spanish study by Casas et al. (2013).
DEHP, BBzP, DnBP and BPA, but not DiNP, are banned from personal
care products and cosmetics in the EU (EC, 2009) whereas DEP, the par-
ent compound of MEP, is the phthalate most commonly used in these
products. Also, plastic containers used for personal care products may
contain phthalates and BPAwith ability tomigrate to the products. Sev-
eral studies have investigated the association between use of personal
care products and urinary phthalate levels. These studies have found as-
sociations between urinary levels of MEP and use of perfume in women
(Just et al., 2010; Parlett et al., 2013), cologne and aftershave in men
(Duty et al., 2005) and lotions in infants (Sathyanarayana et al., 2008).
In the present study, urinary MEP was associated with the use of sun-
screen and eye make-up. Furthermore, we found a correlation between
mother's frequent use of fragrance and higher levels of DiNP metabo-
lites, which was not studied in the previous studies.
Parabens are widely used in cosmetics, thus it is not surprising that
urinary levels of MetP, EthP and ProP were associated with the use of
personal care products (lotion, sunscreen and make-up). Also previous
studies have shown signiﬁcant associations between self-reported use
of lotions and elevated plasma and urinary levels of parabens (Den
Hond et al., 2013; Sandanger et al., 2011). The reason for these particu-
lar associations is probably that lotions and other products that are
applied to a large area of the skin and not washed off are more likely
to be absorbed than products that are washed off, such as shampoo. An-
other interesting observation in the current study was that mothers
who regularly used plastic gloves had higher levels of MetP and ProP
which is not due to the plastic per se, but possibly lotion or powder
used as inner coating of gloves.
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duction of toys within the EU, but they may still be detected in some
of these products (KEMI, 2013). In the current study, the levels of
DEHP metabolites, MnBP and MBzP were elevated in children playing
with plastic toys, but the associations were not statistically signiﬁcant.
We could not identify any previous study investigating the possible
association between toys and exposure to phthalates in Europe.
Most metabolites were detected above the LOD in urine of both
mothers and their children. Therewere generally fairly good correlations
between the metabolite concentrations in urine between mothers and
their children, indicating similar exposure patterns inmother–child cou-
ples. Especially the correlation of MBzP was strong, probably reﬂecting
common exposure sources, such as PVC in the home environment. Chil-
drenhad generally higher levels of phthalates reﬂecting their higher con-
sumption of food per kg bodyweight, but lower levels of parabens and
MEP reﬂecting mother's more frequent use of personal care products
and cosmetics. This pattern is consistent with other studies of children
and adults (CDC, 2013; Frederiksen et al., 2013b; Health Canada, 2013).
The creatinine-adjusted levels of DEHP, DiNP, MnBP, BPA and MetP
were higher in younger than in older children. However, age was signif-
icantly correlated with creatinine, and if unadjusted levels were used for
the analysis, only DiNP remained signiﬁcantly associated with age. Also
in the German GerES IV study, higher urinary levels of phthalates, and
to some extent BPA, were found in younger than in older children
(Becker et al., 2009). The levels of ButP and TCS were below the LOD in
most urine samples and BenPwas not detected in any sample, indicating
a low exposure to these compounds in the general Swedish population.
Decreasing levels of TCS have been reported in sewage from Swedish
waste water treatment plants, indicating a decreased usage of TCS in
products (Haglund and Olofsson, 2011).
The quality of the data gathering and chemical analyses in the cur-
rent study were strengthened by applying a harmonized methodologi-
cal approach elaborated by a consortium with representatives from
several European countries. The harmonized approach also enables
comparison of urinary levels of contaminants on the European level.
Compared to 13–16 other European countries participating in the
same harmonization program, the Swedish levels of DEHP metabolites
and MEP in urine were close to the average levels in Europe, whereas
the levels of MBzP and MnBP were higher than in the other countries
(Den Hond et al., in press). The levels of BPA in Sweden were among
the lowest compared to the levels in the other ﬁve participating coun-
tries that analyzed BPA (Covaci et al., in press). When compared to
studies of children and women of childbearing age outside the har-
monization program, the urinary levels of phthalates and BPA in
the current study were in the same magnitude as levels found in
studies from US, Canada, Netherlands and Norway (CDC, 2009;
CDC, 2013; Health Canada, 2013; Ye et al., 2008; Ye et al., 2009).
The levels of DEHP metabolites and MEP in the current study were
generally among the lowest, whereas the levels of MnBP were
among the highest compared to these studies. The levels of parabens
in the current study were among the lowest and the levels of TCS
were remarkably lower compared with studies from Spain, US and
Denmark (Calafat et al., 2010; Casas et al., 2011; Frederiksen et al.,
2013b).
The analyses of determinants of exposure based on questionnaire
data should be interpreted with caution and the results should be
regarded as indications of potentially important exposure sources for
these compounds. The number of participants was fairly low, thus the
statistical power was limited and a few random high values may get
unbalanced importance in subgroups containing few participants.
The number of exposure sources covered by the questionnaire was lim-
ited and some questions may serve as dummies for other related
source–exposure relationships than the ones covered here.
Given the frequent use of products containing the studied com-
pounds, recurrent exposure over time is likely to occur. A single urine
sample may therefore reasonably represent an individual's ongoingexposure (Christensen et al., 2012; Frederiksen et al., 2013a;
Mouritsen et al., 2013; Smith et al., 2012). In the current study, ﬁrst
morning urine sampling was applied, which has been shown to reason-
ably reﬂect the individual exposure (except for BPA). Adjustment for
creatinine is used to correct for dilution in individual urine samples.
However, the creatinine excretion varies with factors such as age, gen-
der and ethnicity (Barr et al., 2005). Therefore, direct comparisons of
creatinine-adjusted levels between different groups of the population,
e.g. mothers and children or children of various ages, should be
interpreted with caution.
5. Conclusions
To our knowledge this is the ﬁrst study examining exposure
determinants for phthalates, BPA, parabens and TCS in Swedish
mother–child couples. Phthalates, BPA and parabens were signiﬁcantly
correlated to certain foods and personal care products which were ex-
pected to be relevant exposure sources for these contaminants. The
levels were fairly well correlated between the mothers and their chil-
dren. For both mothers and children, urinary levels of phthalates were
generally associated with food consumption whereas the levels of
parabens were associated with use of cosmetics and personal care
products. The urinary levels of the studied chemicals were in the same
magnitude as in previous studies from other countries, although the
levels of TCS were much lower.
Acknowledgment
The studywas partly funded and carried outwithin the framework of
the DEMOCOPHES (LIFE+Programme DG Environment—Life09 ENV/
BE000410) and COPHES (7th Framework Programme DG Research —
No. 244237) projects, which aimed to harmonize biomonitoring
throughout Europe, and the Swedish National Environmental Monitor-
ing Program, coordinated by Swedish EPA (NV-734-11/2151102). We
greatly acknowledge the participating women and children and the
technical assistance of B Norrfors and L-M Lundmark.
References
Barr D, Wilder L, Caudill S, Gonzalez A, Needham L, Pirkle J. Urinary creatinine concentra-
tions in the U.S. population: implications for urinary biologic monitoring measure-
ments. Environ Health Perspect 2005;113(2):192–200.
Becker K, Goen T, Seiwert M, Conrad A, Pick-Fuss H, Muller J, et al. GerES IV: phthalate
metabolites and bisphenol A in urine of German children. Int J Hyg Environ Health
2009;212(6):685–92.
Becker K, Seiwert M, Casteleyn L, Joas R, Joas A, Biot P, et al. A systematic approach for
designing a HBM Pilot Study for Europe. Int J Hyg Environ Health 2014;217(2–3):
312–22.
Bedoux G, Roig B, Thomas O, Dupont V, Le Bot B. Occurrence and toxicity of antimicrobial
triclosan and by-products in the environment. Environ Sci Pollut Res Int 2012;19(4):
1044–65.
Beronius A, Rudén C, Håkansson H, Hanberg A. Risk to all or none? A comparative analysis
of controversies in the health risk assessment of bisphenol A. Reprod Toxicol 2010;
29(2):132–46.
Boberg J, Taxvig C, Christiansen S, Hass U. Possible endocrine disrupting effects of
parabens and their metabolites. Reprod Toxicol 2010;30(2):301–12.
Bornehag C, Lundgren B, Weschler C, Sigsgaard T, Hagerhed-Engman L, Sundell J.
Phthalates in indoor dust and their association with building characteristics. Environ
Health Perspect 2005;113(10):1399–404.
Calafat A, Ye X, Wong L, Bishop A, Needham L. Urinary concentrations of four parabens in
the U.S. population: NHANES 2005–2006. Environ Health Perspect 2010;118(5):
679–85.
Cao X, Perez-Locas C, Dufresne G, Clement G, Popovic S, Beraldin F, et al. Concentrations of
bisphenol A in the composite food samples from the 2008 Canadian total diet study
in Quebec City and dietary intake estimates. Food Addit Contam Part A Chem Anal
Control Expo Risk Assess 2011;28(6):791–8.
Carlstedt F, Jönsson B, Bornehag C. PVC ﬂooring is related to human uptake of phthalates
in infants. Indoor Air 2013;23(1):32–9.
Casas L, Fernández M, Llop S, Guxens M, Ballester F, Olea N, et al. Urinary concentrations
of phthalates and phenols in a population of Spanish pregnant women and children.
Environ Int 2011;37(5):858–66.
Casas M, Valvi D, Luque N, Ballesteros-Gomez A, Carsin AE, Fernandez MF, et al. Dietary
and sociodemographic determinants of bisphenol A urine concentrations in pregnant
women and children. Environ Int 2013;56:10–8.
332 K. Larsson et al. / Environment International 73 (2014) 323–333CDC. Fourth National Report on Human Exposure to Environmental Chemicals. Centers
for Disease Control and Prevention; 2009.
CDC. Fourth National Report on Human Exposure to Environmental Chemicals— updated
tables, September 2013. Centers for Disease Control and Prevention; 2013.
Christensen K, Lorber M, Koch H, Kolossa-Gehring M, Morgan M. Population vari-
ability of phthalate metabolites and bisphenol A concentrations in spot urine
samples versus 24- or 48-h collections. J Expo Sci Environ Epidemiol 2012;
22(6):632–40.
Colacino JA, Harris TR, Schecter A. Dietary intake is associated with phthalate body burden
in a nationally representative sample. EnvironHealth Perspect 2010;118(7):998–1003.
Committee on Toxicity. COT statement on dietary exposure to phthalates— data from the
total diet study (TDS). The Committee on Toxicity of Chemicals in Food, Consumer
Products and the Environment; 2011 [Available from: http://cot.food.gov.uk/].
Covaci A, Den Hond E, Geens T, Govarts E, Koppen G, Frederiksen H, et al. Urinary BPA
measurements in children andmothers from six Europeanmember states: overall re-
sults and determinants of exposure. Environ Res 2014. (in press).
Crofton KM, Paul KB, Devito MJ, Hedge JM. Short-term in vivo exposure to the water
contaminant triclosan: evidence for disruption of thyroxine. Environ Toxicol
Pharmacol 2007;24(2):194–7.
Dann AB, Hontela A. Triclosan: environmental exposure, toxicity and mechanisms of
action. J Appl Toxicol 2011;31(4):285–311.
Den Hond E, Paulussen M, Geens T, Bruckers L, Baeyens W, David F, et al. Biomarkers of
human exposure to personal care products: results from the Flemish Environment
and Health Study (FLEHS 2007–2011). Sci Total Environ 2013;463–464:102–10.
Den Hond E, Govarts E, Willems H, Smolders R, Casteleyn L, Kolossa-Gehring M, et al. The
ﬁrst steps towards harmonised human biomonitoring in Europe. Environ Health
Perspect 2014. (in press).
Duty SM, Ackerman RM, Calafat AM, Hauser R. Personal care product use predicts urinary
concentrations of some phthalate monoesters. Environ Health Perspect 2005;
113(11):1530–5.
EC (European Commission). European parliament and council directive no 95/2/EC of 20
February 1995 on food additives other than colours and sweeteners. European
Commission; 1995.
EC (European Commission). Directive 2005/84/EC of the European Parliament and of the
Council of 14 December 2005. amending for the 22nd time Council Directive 76/769/
EEC on the approximation of the laws, regulations and administrative provisions of
the Member States relating to restrictions on the marketing and use of certain
dangerous substances and preparations (phthalates in toys and childcare articles).
Off J Eur Union 2005;L 344(40).
EC (European Commission). Commission Directive 2007/19/EC of March 30 2007.
Amending Directive 2002/72/EC relating to plastic materials and articles intended
to come into contact with food and Council Directive 85/572/EEC laying down the
list of stimulants to be used for testing migration of constituents of plastic materials
and articles intended to come into contact with foodstuffs. Off J Eur Union 2007;L
97(17).
EC (European Commission). Regulation (EC) No 1223/2009 of the European Parliament
and of the Council of 30 November 2009 on cosmetic products. Off J Eur Union
2009;L 342(59).
EC (European Commission). Commission decision of 19 March 2010 concerning the non-
inclusion of 2,4,4′-trichloro-2′-hydroxydiphenyl ether in the Union list of additives
which may be used in the manufacture of plastic materials and articles intended to
come into contact with foodstuffs under Directive 2002/72/EC. Off J Eur Union
2010;L 75(25).
EC (European Commission). Commission directive 2011/8/EU of 28 January 2011
amending directive 2002/72/EC as regards the restriction of use of bisphenol A in
plastic infant feeding bottles. Off J Eur Union 2011;L 26(11).
Fierens T, Servaes K, Van Holderbeke M, Geerts L, De Henauw S, Sioen I, et al. Analysis of
phthalates in food products and packaging materials sold on the Belgian market.
Food Chem Toxicol 2012;50(7):2575–83.
Foster PM. Disruption of reproductive development in male rat offspring following in
utero exposure to phthalate esters. Int J Androl 2006;29(1):140–7. [discussion
181–145].
Frederiksen H, Skakkebaek NE, Andersson AM. Metabolism of phthalates in humans. Mol
Nutr Food Res 2007;51(7):899–911.
Frederiksen H, Kranich SK, Jorgensen N, Taboureau O, Petersen JH, Andersson AM. Tem-
poral variability in urinary phthalate metabolite excretion based on spot, morning,
and 24-h urine samples: considerations for epidemiological studies. Environ Sci
Technol 2013a;47(2):958–67.
Frederiksen H, Nielsen JK, Morck TA, Hansen PW, Jensen JF, Nielsen O, et al. Urinary
excretion of phthalate metabolites, phenols and parabens in rural and urban Danish
mother–child pairs. Int J Hyg Environ Health 2013b;216(6):772–83.
Fromme H, Gruber L, Schlummer M, Wolz G, Bohmer S, Angerer J, et al. Intake of
phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assess-
ment Survey based on duplicate diet samples and biomonitoring data. Environ Int
2007;33(8):1012–20.
Geens T, Roosens L, Neels H, Covaci A. Assessment of human exposure to bisphenol-A,
triclosan and tetrabromobisphenol-A through indoor dust intake in Belgium.
Chemosphere 2009;76(6):755–60.
Geens T, Aerts D, Berthot C, Bourguignon JP, Goeyens L, Lecomte P, et al. A review of
dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 2012;50(10):
3725–40.
Gray Jr LE, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L. Perinatal exposure to the
phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differenti-
ation of the male rat. Toxicol Sci 2000;58(2):350–65.
Haglund P, Olofsson U. Environmental monitoring of outgoing water and sludge from
Swedish waterworks. (Miljöövervakning av utgående vatten & slam från svenskaavloppsreningsverk. Resultat från år 2010 och en sammanfattning av slamresultaten
för åren 2004–2010.). Rapport till nationella miljöövervakningen; 2011 [In Swedish].
Health Canada. Second Report on Human Biomonitoring of Environmental Chemicals in
Canada. Results of the Canadian Health Measures Survey Cycle 2 (2009–2011).
Ottawa: Health Canada; 2013.
Janjua NR, Frederiksen H, Skakkebaek NE, Wulf HC, Andersson AM. Urinary excretion of
phthalates and paraben after repeated whole-body topical application in humans.
Int J Androl 2008;31(2):118–30.
Just AC, Adibi JJ, Rundle AG, Calafat AM, Camann DE, Hauser R, et al. Urinary and air
phthalate concentrations and self-reported use of personal care products among mi-
nority pregnant women in New York City. J Expo Sci Environ Epidemiol 2010;20(7):
625–33.
KEMI. Swedish Chemicals Agency's control of toys 2012–2013 (Kemikalieinspektionens
kontroll av leksaker 2012–2013). Tillsyn 6/13: Kemikalieinpektionen; 2013 [In
swedish].
Koch HM, Lorber M, Christensen KL, Palmke C, Koslitz S, Bruning T. Identifying sources of
phthalate exposure with human biomonitoring: results of a 48 h fasting study with
urine collection and personal activity patterns. Int J Hyg Environ Health 2013;
216(6):672–81.
Kuklenyik Z, Ekong J, Cutchins C, Needham L, Calafat A. Simultaneous measurement of
urinary bisphenol A and alkylphenols by automated solid-phase extractive derivati-
zation gas chromatography/mass spectrometry. Anal Chem 2003;75(24):6820–5.
Kumar V, Chakraborty A, Kural MR, Roy P. Alteration of testicular steroidogenesis and
histopathology of reproductive system in male rats treated with triclosan. Reprod
Toxicol 2009;27(2):177–85.
Larsen K. Creatinine assay by a reaction-kinetic principle. Clin ChimActa 1972;41:209–17.
Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Main KM, Skakkebaek NE, et al. Tempo-
ral variability in urinary excretion of bisphenol A and seven other phenols in spot,
morning, and 24-h urine samples. Environ Res 2013;126:164–70.
Loganathan SN, Kannan K. Occurrence of bisphenol A in indoor dust from two locations in
the eastern United States and implications for human exposures. Arch Environ
Contam Toxicol 2011;61(1):68–73.
Mouritsen A, Frederiksen H, Sorensen K, Aksglaede L, Hagen C, Skakkebaek NE, et al.
Urinary phthalates from 168 girls and boys measured twice a year during a 5-year
period: associations with adrenal androgen levels and puberty. J Clin Endocrinol
Metab 2013;98(9):3755–64.
Mylchreest E, Wallace DG, Cattley RC, Foster PM. Dose-dependent alterations in
androgen-regulated male reproductive development in rats exposed to Di(n-butyl)
phthalate during late gestation. Toxicol Sci 2000;55(1):143–51.
Parlett LE, Calafat AM, Swan SH. Women's exposure to phthalates in relation to use of
personal care products. J Expo Sci Environ Epidemiol 2013;23(2):197–206.
Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. In vivo
effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 2007;24(2):
199–224.
Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP. Some alkyl hydroxy benzoate preser-
vatives (parabens) are estrogenic. Toxicol Appl Pharmacol 1998;153(1):12–9.
Sandanger TM, Huber S, Moe MK, Braathen T, Leknes H, Lund E. Plasma concentra-
tions of parabens in postmenopausal women and self-reported use of personal
care products: the NOWAC postgenome study. J Expo Sci Environ Epidemiol
2011;21(6):595–600.
Sathyanarayana S, Karr CJ, Lozano P, Brown E, Calafat AM, Liu F, et al. Baby care products:
possible sources of infant phthalate exposure. Pediatrics 2008;121(2):e260–8.
SCCP (Scientiﬁc Committee on Consumer Products). Opinion on triclosan. COLIPA no P42
SCCP/1192/08; 2009.
SCCS (Scientiﬁc Committee on Consumer Safety). Opinion on parabens. COLIPA no P82
SCCS/1348/10; 2011.
Schecter A,Malik N,HaffnerD, Smith S, Harris TR, PaepkeO, et al. Bisphenol A (BPA) inU.S.
food. Environ Sci Technol 2010;44(24):9425–30.
Schecter A, Lorber M, Guo Y, Wu Q, Yun SH, Kannan K, et al. Phthalate concentrations and
dietary exposure from food purchased in New York State. Environ Health Perspect
2013;121(4):473–94. [494e471-474].
Schindler BK, Esteban M, Koch HM, Castano A, Koslitz S, Canas A, et al. The European
COPHES/DEMOCOPHES project: towards transnational comparability and reliabil-
ity of human biomonitoring results. Int J Hyg Environ Health 2013;15(13).
[00157-00150].
Sioen I, Fierens T, Van Holderbeke M, Geerts L, Bellemans M, De Maeyer M, et al.
Phthalates dietary exposure and food sources for Belgian preschool children and
adults. Environ Int 2012;48:102–8.
Smith KW, Braun JM, Williams PL, Ehrlich S, Correia KF, Calafat AM, et al. Predictors and
variability of urinary paraben concentrations in men and women, including before
and during pregnancy. Environ Health Perspect 2012;120(11):1538–43.
Suzuki Y, Yoshinaga J, Mizumoto Y, Serizawa S, Shiraishi H. Foetal exposure to phthalate
esters and anogenital distance in male newborns. Int J Androl 2012;35(3):236–44.
Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital
distance among male infants with prenatal phthalate exposure. Environ Health
Perspect 2005;113(8):1056–61.
Toft G, Jönsson B, Lindh C, Jensen T, Hjollund N, Vested A, et al. Association between
pregnancy loss and urinary phthalate levels around the time of conception. Environ
Health Perspect 2012;120:458–63.
Townsend MK, Franke AA, Li X, Hu FB, Eliassen AH. Within-person reproducibility of
urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among
women in the Nurses' Health Studies: a prospective cohort study. Environ Health
2013;12(1):80.
Völkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of
bisphenol a in humans at low doses following oral administration. Chem Res Toxicol
2002;15(10):1281–7.
333K. Larsson et al. / Environment International 73 (2014) 323–333Völkel W, Bittner N, Dekant W. Quantitation of bisphenol A and bisphenol A glucuronide
in biological samples by high performance liquid chromatography-tandem mass
spectrometry. Drug Metab Dispos 2005;33(11):1748–57.
WHO. Biological monitoring of chemical exposure in the workplace. Geneva: World
Health Organization; 1996.
Witorsch RJ, Thomas JA. Personal care products and endocrine disruption: a critical
review of the literature. Crit Rev Toxicol 2010;40(Suppl. 3):1–30.
Wittassek M, Angerer J. Phthalates: metabolism and exposure. Int J Androl 2008;31(2):
131–8.
Wittassek M, Koch HM, Angerer J, Bruning T. Assessing exposure to phthalates — the
human biomonitoring approach. Mol Nutr Food Res 2011;55(1):7–31.
Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. What are the sources of
exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal
2006;26(3):803–24.
Ye X, Bishop AM, Reidy JA, Needham LL, Calafat AM. Parabens as urinary biomarkers of
exposure in humans. Environ Health Perspect 2006a;114(12):1843–6.
Ye X, Kuklenyik Z, Bishop AM, Needham LL, Calafat AM. Quantiﬁcation of the urinary
concentrations of parabens in humans by on-line solid phase extraction-highperformance liquid chromatography-isotope dilution tandem mass spectrometry. J
Chromatogr B 2006b;844(1):53–9.
Ye X, Pierik FH, Hauser R, Duty S, Angerer J, Park MM, et al. Urinary metabolite concentra-
tions of organophosphorous pesticides, bisphenol A, and phthalates among pregnant
women in Rotterdam, the Netherlands: the Generation R study. Environ Res 2008;
108(2):260–7.
Ye X, Pierik FH, Angerer J, Meltzer HM, Jaddoe VW, Tiemeier H, et al. Levels of metabolites
of organophosphate pesticides, phthalates, and bisphenol A in pooled urine speci-
mens from pregnantwomen participating in the NorwegianMother and Child Cohort
Study (MoBa). Int J Hyg Environ Health 2009;212(5):481–91.
Ye X, Wong LY, Bishop AM, Calafat AM. Variability of urinary concentrations of bisphenol
A in spot samples, ﬁrst morning voids, and 24-hour collections. Environ Health
Perspect 2011;119(7):983–8.
Zorrilla LM, Gibson EK, Jeffay SC, Crofton KM, Setzer WR, Cooper RL, et al. The effects of
triclosan on puberty and thyroid hormones in male Wistar rats. Toxicol Sci 2009;
107(1):56–64.
